12 Aug, 2024
The end-users of the biological safety testing products & services include pharmaceutical and biotechnology companies, contract development, and manufacturing organizations. Developing countries such as India and China are heavily investing in the healthcare infrastructure and research laboratories. Research laboratories offer extensive capacities such as drug discovery and cell line development and culture that require biologics safety testing to develop pathogen-free products and reliable services. The biological safety testing products and services require the expertise of the analysts to achieve optimal efficacy. However, the lack of skilled professionals might hamper the market growth to a certain extent.
Increasing focus on R&D activities accelerates the demand for biological safety testing products & services. The biologic safety testing products and services aids in avoiding cross-contamination, mix-ups, and leakage. Growth of the pharmaceutical and biotechnology industries drives the biological safety testing products and services market. As per the Indian Brand Equity Foundation, the Indian Biotech Industry market is anticipated to reach USD 100 billion by 2020 from USD 11 billion in 2016.